Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

MIT scientists find a hidden cancer risk of the keto diet

A ketogenic diet increased small-intestinal tumors in cancer-prone mice while reducing tumors in the colon, revealing a strikingly different response within neighboring parts of the gut. Researchers traced the increased risk not to ketones, but to the way intestinal stem cells processed the diet’s high levels of fat. That fat-burning activity pushed the cells to multiply more rapidly, potentially…

We haven't written up this one. ScienceDaily Health has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at sciencedaily.com →

More in Health & Medicine

Celltrion Launches Omlyclo in U.S., Targeting Early Lead in Omalizumab Biosimilar Market

Celltrion has entered the U.S. market for omalizumab biosimilars with the launch of Omlyclo, aiming to replicate the early market penetration it achieved in Europe and establish the product as a key…

  • Celltrion launches Omlyclo, first omalizumab biosimilar in U.S.
  • Introduced on October 5, offering 15% lower cost than reference product
  • Recognized as preferred drug by major PBMs, securing U.S. formulary placement

More from Tuesday 6 October →